| GeneLibs

题目:: Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug development.
作者:: Kelloff(Gary J),Sigman(Caroline C)
状态:: 发布时间2007-06-22 , 更新时间 2007-06-22
期刊:: Nat Rev Cancer
摘要:: Despite significant interest from the research community and the population in general, drug approvals for cancer prevention and/or cancer risk reduction are few. This is due, in part, to the requirement that new cancer-preventive drugs must first be shown to be efficacious in reducing cancer incidence or mortality. Moreover, such drugs need to have proven safety for long-term administration. This process can be improved by focusing on precancer (intraepithelial neoplasia) to identify subjects at risk and prove efficacy in shorter, smaller trials as well as on detecting early markers of potential toxicities of chronic exposure to cancer-preventive drug regimens.
语言:: eng
DOI:: 10.1038/nrc2154

文献库文献相关信息